Smith-Lemli-Opitz Syndrome: Clinical Trials

18 trials for Smith-Lemli-Opitz Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 terminated, 2 unknown, 2 withdrawn. 8 Phase 2, 3 Phase 1, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 28Completed 5, Unknown 2, Withdrawn 1
Phase 13Completed 3
Not applicable2Terminated 2

Follow Smith-Lemli-Opitz Syndrome: new trials by email Literature Review of Smith-Lemli-Opitz Syndrome trials Research Report on Smith-Lemli-Opitz Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Functional Near-Infrared Spectroscopy (fNIRS) Combined With Diffuse Correlation Spectroscopy (DCS) in Neurocognitive Disease as Compared to Healthy Neurotypical Controls
Juvenile Neuronal Ceroid Lipofuscinosis, Smith-Lemli-Opitz Syndrome
CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)732023-01-232026-10-13
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism
Smith Lemli Opitz Syndrome, CHILD Syndrome
RecruitingEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2502021-06-232026-08-17
Smith-Lemli-Opitz Syndrome and Cholic Acid
Cholic Acid - Smith-Lemli-Opitz Syndrome
Phase 1 / Phase 2CompletedUniversity of Nebraska122021-03-272024-04-30
Early Check: Expanded Screening in Newborns
Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome
Active not recruitingRTI International300002018-10-152026-07-01
SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
Simvastatin, Lactose - Smith-Lemli-Opitz Syndrome
Not applicableTerminatedOregon Health and Science University12011-09-012019-10-01
Novel Treatment for Syndromic Ichthyoses
Lovastatin - Syndromic Ichthyoses, CHILD Syndrome
Phase 2WithdrawnNorthwestern University2011-07-012015-05-19
A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome
Smith-Lemi-Opitz Syndrome
WithdrawnEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2011-06-292017-07-02
Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome
Cholesterol supplementation - Smith-Lemli-Opitz Syndrome
Not applicableTerminatedOregon Health and Science University212011-01-012019-05-23
Cholesterol in ASD: Characterization and Treatment
Cholesterol - Autism, Asperger Disorder
Phase 1 / Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)442009-07-282018-07-05
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
Antioxidants, Cholesterol - Smith-Lemli-Opitz Syndrome, Cone-Rod Dystrophy
Phase 2UnknownUniversity of Colorado, Denver1002008-12-012024-05-08
Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome
Egg yolk preparation with cholesterol, Egg substitute, without cholesterol - Smith-Lemli-Opitz Syndrome
Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)132005-06-012016-01-29
Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Simvastatin Susp., OraPlus - Smith-Lemli-Opitz Syndrome
Phase 2CompletedForbes Porter, M.D.232003-07-012014-06-06
Estimation of the Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans
Smith-Lemli-Opitz Syndrome
CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)20002001-06-012008-03-04
Prenatal Screening For Smith-Lemli-Opitz Syndrome
Smith-Lemli-Opitz Syndrome, Pregnancy
CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)18002001-04-012007-07-02
Study of Smith-Lemli-Opitz Syndrome
Cholesterol Suspension, CRH, Cholesterol - Smith-Lemli-Opitz Syndrome
CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1301998-09-132026-10-07
Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
crystalline cholesterol oil-based suspension - Smith-Lemli-Opitz Syndrome
Phase 1 / Phase 2CompletedBoston Children's Hospital231998-01-012017-10-20
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
diet - Smith-Lemli-Opitz Syndrome
Phase 2UnknownNational Center for Research Resources (NCRR)51995-11-012005-06-24

Narrower conditions

3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (2)  ·  Acidemia, isovaleric (2)  ·  Anemia, Sickle Cell (2)  ·  Argininosuccinic Aciduria (2)  ·  Ataxia with vitamin E deficiency (2)  ·  Basal ganglia disease, biotin-responsive (2)  ·  Beta ketothiolase deficiency (2)  ·  Biotinidase Deficiency (2)  ·  Brown-Vialetto-Van Laere syndrome (2)  ·  Carbamoyl-Phosphate Synthase I Deficiency Disease (2)  ·  Carnitine palmitoyl transferase 1A deficiency (2)  ·  Carnitine palmitoyl transferase 2 deficiency (2)  ·  Carnitine-Acylcarnitine Translocase Deficiency (2)  ·  Citrullinemia (2)

Broader conditions

Abnormalities, Multiple (18)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (18)  ·  Dyslipidemias (18)  ·  Lipid Metabolism Disorders (18)  ·  Lipid Metabolism, Inborn Errors (18)  ·  Metabolic Diseases (18)  ·  Metabolism, Inborn Errors (18)  ·  Nutritional and Metabolic Diseases (18)  ·  Steroid Metabolism, Inborn Errors (18)  ·  Congenital Abnormalities (17)  ·  Genetic Diseases, Inborn (17)  ·  Nervous System Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Mental Disorders (5)  ·  Neurologic Manifestations (5)

Interventions

Cholesterol (4)  ·  Antioxidants (1)  ·  Cholic Acid (1)  ·  Diet (1)  ·  Eggs (1)  ·  Lactose (1)  ·  Lovastatin (1)  ·  Simvastatin (1)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (8)  ·  Oregon Health and Science University (2)  ·  Boston Children's Hospital (1)  ·  Centre Hospitalier Universitaire de Liege (1)  ·  Forbes Porter, M.D. (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Northwestern University (1)  ·  RTI International (1)  ·  University of Colorado, Denver (1)  ·  University of Nebraska (1)

Countries

United States (15)  ·  Belgium (1)

Top investigators

Forbes D Porter, M.D. (6)  ·  Ellen R Elias, MD (2)  ·  Amy S Paller, MD (1)  ·  Curt Scharfe, MD, PhD (1)  ·  Forbes D Porter, MD (1)  ·  James E. Haddow, M.D. (1)  ·  Jean-Baptiste Roullet, PhD (1)  ·  Laurent Servais (1)  ·  Mira Irons, M.D. (1)  ·  Robert Steiner, MD (1)  ·  William B Rizzo, MD (1)  ·  William Connor (1)

Results publications

PMID 27053961, PMID 39271956, PMID 14605787, PMID 14662594, PMID 31315600, PMID 35142618, PMID 36721240, PMID 8209913, PMID 9024564, PMID 9024565

NIH funding

R01HL073980 (1)